State Of Alaska, Department Of Revenue Emergent Bio Solutions Inc. Transaction History

State Of Alaska, Department Of Revenue

$9.42 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$7.35 - $13.21 $6,335 - $11,387	-862 Reduced 2.84%	29,542 $217,000
Q1 2023 Apr 17, 2023	SELL	$7.79 - $16.29 $3,996 - $8,356	-513 Reduced 1.66%	30,404 $314,000
Q4 2022 Jan 11, 2023	BUY	$11.0 - $21.45 $2,123 - $4,139	193 Added 0.63%	30,917 $365,000
Q3 2022 Oct 20, 2022	SELL	$20.09 - $35.8 $62,299 - $111,015	-3,101 Reduced 9.17%	30,724 $644,000
Q2 2022 Jul 08, 2022	BUY	$27.42 - $43.63 $11,790 - $18,760	430 Added 1.29%	33,825 $1.05 Million
Q1 2022 Apr 14, 2022	SELL	$36.48 - $52.22 $18,604 - $26,632	-510 Reduced 1.5%	33,395 $1.37 Million
Q4 2021 Jan 12, 2022	BUY	$33.11 - $55.01 $873,011 - $1.45 Million	26,367 Added 349.79%	33,905 $1.47 Million
Q3 2021 Oct 07, 2021	BUY	$50.07 - $66.05 $25,335 - $33,421	506 Added 7.2%	7,538 $377,000
Q2 2021 Jul 12, 2021	SELL	$56.61 - $80.46 $3,679 - $5,229	-65 Reduced 0.92%	7,032 $442,000
Q1 2021 Apr 09, 2021	SELL	$86.23 - $125.19 $19,229 - $27,917	-223 Reduced 3.05%	7,097 $659,000
Q4 2020 Jan 08, 2021	SELL	$79.17 - $111.47 $26,838 - $37,788	-339 Reduced 4.43%	7,320 $655,000
Q3 2020 Oct 05, 2020	SELL	$81.91 - $134.94 $2.82 Million - $4.64 Million	-34,378 Reduced 81.78%	7,659 $791,000
Q2 2020 Jul 06, 2020	BUY	$54.33 - $89.52 $72,258 - $119,061	1,330 Added 3.27%	42,037 $3.32 Million
Q1 2020 Apr 06, 2020	BUY	$49.34 - $68.76 $373,503 - $520,513	7,570 Added 22.84%	40,707 $2.36 Million
Q4 2019 Jan 07, 2020	SELL	$51.21 - $59.06 $28,677 - $33,073	-560 Reduced 1.66%	33,137 $1.79 Million
Q3 2019 Oct 02, 2019	BUY	$40.6 - $57.2 $742,939 - $1.05 Million	18,299 Added 118.84%	33,697 $1.76 Million
Q2 2019 Jul 23, 2019	BUY	$39.92 - $53.86 $8,343 - $11,256	209 Added 1.38%	15,398 $743,000
Q1 2019 Apr 09, 2019	BUY	$48.23 - $66.16 $9,646 - $13,232	200 Added 1.33%	15,189 $767,000
Q4 2018 Jan 10, 2019	BUY	$55.63 - $73.24 $40,999 - $53,977	737 Added 5.17%	14,989 $888,000
Q3 2018 Oct 09, 2018	BUY	$52.05 - $66.51 $139,546 - $178,313	2,681 Added 23.17%	14,252 $938,000
Q2 2018 Jul 10, 2018	BUY	$48.33 - $55.64 $12,082 - $13,910	250 Added 2.21%	11,571 $584,000
Q1 2018 Apr 19, 2018	BUY	$44.44 - $54.39 $192,869 - $236,052	4,340 Added 62.17%	11,321 $596,000
Q4 2017 Jan 19, 2018	BUY	$37.77 - $47.75 $2,643 - $3,342	70 Added 1.01%	6,981 $324,000
Q3 2017 Oct 16, 2017	BUY	$34.14 - $40.45 $235,941 - $279,549	6,911	6,911 $279,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$32.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$28.6 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$18.7 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Account